1. Adjunctive TMP-SMX therapy in patients with cutaneous abscesses resulted in a significantly higher clinical cure rates compared to placebo. 2. Adjunctive TMP-SMX therapy in patients with cutaneous abscesses was associated with significantly lower rates of secondary surgical drainage and new skin infections at different sites compared to the placebo group. Evidence Rating Level:
↧
